Close Menu

NEW YORK (GenomeWeb) — Curetis announced today that it has signed exclusive distribution agreements for its PCR-based diagnostic assays in certain North African and Latin American markets.

As part of the arrangements, Curetis has also secured commitments for the purchase of 45 of its Unyvero molecular diagnostic systems and minimum purchases of its test cartridges.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.